비교리스트

 카트 문의
시장보고서
상품코드
1485767

나노의학 시장 : 양식별, 용도별, 적응증별, 분자 유형별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Nanomedicines Market, By Modality, By Application, By Indication, By Molecule Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 311 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

나노의학 시장 규모는 2023년 2억 3,104만 달러로 2024-2032년 연평균 12.92% 성장할 것으로 예상됩니다.

나노의학 시장 - 시장 역학

약물전달에 나노기술 활용 급증으로 시장 수요 촉진

나노기술을 이용한 약물전달은 표적에 대한 약물전달, 약효 강화, 부작용 감소 등의 장점으로 인해 빠르게 성장하고 있습니다. 이러한 성장은 연구개발에 대한 투자 증가, 나노 소재 및 약물전달 기술의 발전, 개인 맞춤형 의료 및 정밀 의료 솔루션에 대한 수요 증가에 힘입어 성장세를 보이고 있습니다. 또한, COVID-19 팬데믹은 바이러스에 대응하기 위한 나노의학 기반 백신 및 치료제의 개발로 인해 약물전달에 나노기술의 채택을 더욱 가속화시키고 있습니다.

나노의학 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 12.92%의 CAGR로 성장할 것으로 예상됩니다.

시장 세분화에서 치료는 2023년에 가장 큰 시장 점유율을 보일 것으로 예상됩니다.

용도별로는 약물전달이 2023년 주요 유형으로 꼽혔습니다.

적응증별로는 2023년 심혈관 질환이 주요 유형으로 나타났습니다.

지역별로는 북미가 2023년에 수익을 창출하는 주요 시장으로 꼽혔습니다.

나노의학 시장 - 세분화 분석:

세계 나노의학 시장은 양식, 용도, 적응증, 분자 유형 및 지역에 따라 세분화됩니다.

시장은 양식에 따라 두 가지 범주로 나뉩니다: 치료는 특정 질병이나 질환을 대상으로 치료 목적으로 나노의학을 사용하는 것입니다. 진단은 질병이나 상태를 진단하기 위해 나노 기술을 활용하며, 종종 고급 이미징 및 감지 방법을 사용합니다.

시장은 용도에 따라 두 가지 범주로 나뉩니다: 약물전달은 표적 약물전달, 약효 강화, 부작용 최소화를 위해 나노 의료의 사용에 초점을 맞추고, IVD는 혈액 검사, 유전자 검사 등 체외 진단 테스트에 나노 기술을 활용합니다. 임플란트는 생체 적합성과 성능을 향상시키기 위해 정형외과용 임플란트, 치과용 임플란트 등 의료용 임플란트에 나노 소재를 사용합니다.

나노의학 시장 - 지리적 인사이트

지역적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카으로 나뉩니다. 이 지역들은 사업 진출 국가에 따라 더 세분화되어 있습니다.

북미와 유럽은 선진적인 연구 인프라, 탄탄한 규제 프레임워크, 나노의학 연구개발에 대한 막대한 투자로 주요 시장 진입국입니다. 반면, 아시아태평양은 의료비 지출 증가, 만성질환 유병률 증가, 혁신적인 치료법에 대한 접근성 확대로 인해 큰 성장 잠재력을 보이고 있습니다. 라틴아메리카와 중동 및 아프리카 역시 의료 인프라, 가격, 규제 복잡성 등의 도전과제를 안고 있지만, 시장 확대의 기회를 제공하고 있습니다.

나노의학 시장 - 경쟁 상황:

다수의 주요 기업들이 R&D 투자, 인수합병, 전략적 제휴 등의 전략을 통해 시장을 선점하고 있으며, Abbott Laboratories, Johnson & Johnson, Pfizer와 같은 기업들은 다양한 나노의학 제품 포트폴리오와 광범위한 세계 진출로 시장을 선도하고 있습니다. 시장을 선도하고 있습니다. 또한 Amgen, Gilead Sciences, Novartis와 같은 혁신적인 생명공학 기업들도 획기적인 치료법과 신약 후보물질로 시장 경쟁에 기여하고 있습니다. 치열한 경쟁 속에서 각 업체들은 제품 혁신, 규제 당국의 승인, 시장 확대 노력을 통해 차별화를 꾀하고 있습니다.

목차

제1장 나노의학 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 나노의학의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 나노의학 산업 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 프레임워크 분석

제5장 나노의학 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 나노의학 시장 상황

  • 나노의학 시장 점유율 분석, 2023년
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 나노의학 시장 - 모달리티별

  • 개요
    • 모달리티별 부문 점유율 분석
    • 치료
    • 진단

제8장 나노의학 시장 - 용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 약물전달
    • 체외진단
    • 임플란트
    • 백신
    • 기타

제9장 나노의학 시장 - 적응증별

  • 개요
    • 적응증별 부문 점유율 분석
    • 종양학
    • 감염증
    • 심혈관
    • 신경학

제10장 나노의학 시장 - 분자 유형별

  • 개요
    • 분자 유형별 부문 점유율 분석
    • 나노입자
    • 나노튜브
    • 나노디바이스

제11장 나노의학 시장 - 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제12장 주요 벤더 분석 - 나노의학 업계

  • 경쟁 대시보드
  • 기업 개요
    • Sanofi SA
    • Celgene Corporation
    • Nanobiotix
    • Luminex Corporation
    • Nanospectra Biosciences Inc
    • NanoCarrier Co. Ltd
    • Johnson & Johnson Services Inc
    • Merck &Co., Inc
    • Pfizer, Inc.
    • NanoCarrier Co. Ltd
    • Taiwan Liposome Company Ltd
    • Hoffmann-La Roche AG(Roche)
    • Gilead Science Inc
    • Ipsen SA.
    • 기타

제13장 애널리스트의 전방위 전망

ksm 24.06.05

REPORT HIGHLIGHT

Nanomedicines Market size was valued at USD 231.04 Million in 2023, expanding at a CAGR of 12.92% from 2024 to 2032.

The nanomedicine market encompasses the use of nanotechnology for diagnosing, treating, and preventing diseases at the molecular level, offering targeted delivery and enhanced efficacy in drug delivery and imaging applications. The development of personalized nanomedicines tailored to individual patient profiles, and increasing research focus on combination therapies and multifunctional nanoplatforms. However, restraints in the nanomedicine market include challenges related to regulatory approvals and safety concerns associated with nanomaterials. Opportunities abound in the integration of nanotechnology with other emerging technologies like artificial intelligence and gene editing for precision medicine approaches.

Nanomedicines Market- Market Dynamics

Rapidly increasing utilization of nanotechnology in drug delivery methods to propel market demand

The adoption of nanotechnology-based methods for drug delivery is experiencing rapid growth, driven by the advantages offered in terms of targeted delivery, enhanced drug efficacy, and reduced side effects. This growth is fueled by increasing investments in research and development, advancements in nanomaterials and drug delivery technologies, and a rising demand for personalized and precision medicine solutions. Additionally, the COVID-19 pandemic has further accelerated the adoption of nanotechnology in drug delivery, with the development of nanomedicine-based vaccines and therapeutics to combat the virus.

Nanomedicines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.92% over the forecast period (2024-2032)

Based on Modality segmentation, Treatment was predicted to show maximum market share in the year 2023

Based on application segmentation, Drug Delivery was the leading type in 2023

Based on Indication segmentation, Cardiovascular

was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Nanomedicines Market- Segmentation Analysis:

The Global Nanomedicines Market is segmented on the basis of Modality, Application, Indication, Molecule Type, and Region.

The market is divided into two categories based on Modality: Treatment involves the use of nanomedicines for therapeutic purposes, targeting specific diseases or medical conditions. Diagnostics utilizes nanotechnology for diagnosing diseases or conditions, often through advanced imaging or detection methods.

The market is divided into two categories based on application: Drug Delivery focuses on the use of nanomedicines for targeted drug delivery, enhancing drug efficacy, and minimizing side effects. IVD utilizes nanotechnology for diagnostic tests performed outside the body, such as blood tests or genetic testing. An implant involves the use of nanomaterials in medical implants, such as orthopedic implants or dental implants, to improve biocompatibility and performance.

Nanomedicines Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

North America and Europe stand as key players, boasting advanced research infrastructure, robust regulatory frameworks, and significant investments in nanomedicine research and development. Meanwhile, the Asia-Pacific region demonstrates significant growth potential, driven by rising healthcare expenditures, increasing prevalence of chronic diseases, and expanding access to innovative therapies. Latin America and the Middle East & Africa regions also present opportunities for market expansion, albeit with challenges related to healthcare infrastructure, affordability, and regulatory complexities.

Nanomedicines Market- Competitive Landscape:

Several key players are dominaning the market through strategies such as research and development investments, mergers and acquisitions, and strategic partnerships. Companies like Abbott Laboratories, Johnson & Johnson, and Pfizer lead the market with diverse portfolios of nanomedicine products and extensive global reach. Additionally, innovative biotechnology firms such as Amgen, Gilead Sciences, and Novartis contribute to market competitiveness with groundbreaking therapies and novel drug candidates. As competition intensifies, companies focus on differentiation through product innovation, regulatory approvals, and market expansion efforts.

Recent Developments:

In January 2022, Pfizer Inc. and Acuitas Therapeutics disclosed a development and option agreement, wherein Pfizer will hold the opportunity to license Acuitas' LNP technology for potential utilization in up to ten targets for vaccine or therapeutic development on a non-exclusive basis.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NANOMEDICINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Sanofi SA

Celgene Corporation

Nanobiotix

Luminex Corporation

Nanospectra Biosciences Inc

NanoCarrier Co. Ltd

Johnson & Johnson Services Inc

Merck & Co., Inc

Pfizer, Inc.

NanoCarrier Co. Ltd

Taiwan Liposome Company Ltd

Hoffmann-La Roche AG (Roche)

Gilead Science Inc

Ipsen SA.

Others

GLOBAL NANOMEDICINES MARKET, BY MODALITY- MARKET ANALYSIS, 2019 - 2032

  • Treatment
  • Diagnostics

GLOBAL NANOMEDICINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Delivery
  • IVD
  • Implant
  • Vaccine
  • Others

GLOBAL NANOMEDICINES MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Infectious
  • Cardiovascular
  • Neurological

GLOBAL NANOMEDICINES MARKET, BY MOLECULE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Nanoparticle
  • Nanotube
  • Nanodevice

GLOBAL NANOMEDICINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Nanomedicines Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Nanomedicines Market Snippet by Modality
    • 2.1.2.Nanomedicines Market Snippet by Application
    • 2.1.3.Nanomedicines Market Snippet by Indication
    • 2.1.4.Nanomedicines Market Snippet by Molecule Type
    • 2.1.5.Nanomedicines Market Snippet by Country
    • 2.1.6.Nanomedicines Market Snippet by Region
  • 2.2.Competitive Insights

3.Nanomedicines Key Market Trends

  • 3.1.Nanomedicines Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Nanomedicines Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Nanomedicines Market Opportunities
  • 3.4.Nanomedicines Market Future Trends

4.Nanomedicines Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Nanomedicines Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Nanomedicines Market Landscape

  • 6.1.Nanomedicines Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Nanomedicines Market - By Modality

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Modality, 2023 & 2032 (%)
    • 7.1.2.Treatment
    • 7.1.3.Diagnostics

8.Nanomedicines Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Drug Delivery
    • 8.1.3.IVD
    • 8.1.4.Implant
    • 8.1.5.Vaccine
    • 8.1.6.Others

9.Nanomedicines Market - By Indication

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 9.1.2.Oncology
    • 9.1.3.Infectious
    • 9.1.4.Cardiovascular
    • 9.1.5.Neurological

10.Nanomedicines Market - By Molecule Type

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2.Nanoparticle
    • 10.1.3.Nanotube
    • 10.1.4.Nanodevice

11.Nanomedicines Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Nanomedicines Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Nanomedicines Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Nanomedicines Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Nanomedicines Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Nanomedicines Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Nanomedicines Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.Sanofi SA
    • 12.2.2.Celgene Corporation
    • 12.2.3.Nanobiotix
    • 12.2.4.Luminex Corporation
    • 12.2.5.Nanospectra Biosciences Inc
    • 12.2.6.NanoCarrier Co. Ltd
    • 12.2.7.Johnson & Johnson Services Inc
    • 12.2.8.Merck & Co., Inc
    • 12.2.9.Pfizer, Inc.
    • 12.2.10.NanoCarrier Co. Ltd
    • 12.2.11.Taiwan Liposome Company Ltd
    • 12.2.12.Hoffmann-La Roche AG (Roche)
    • 12.2.13.Gilead Science Inc
    • 12.2.14.Ipsen SA.
    • 12.2.15.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제